Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

Caitlin E. Cox

December 09, 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Todd Neale

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Shelley Wood

November 01, 2021

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

Todd Neale

October 14, 2021

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Daily News

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

Michael O'Riordan

September 27, 2021

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

Advertisement

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Half-Dose DOAC May Be a Good Post-Watchman Option

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content